Colony forming cell (CFC) assay for human hematopoietic cells

Area of Science:

• Hematology
• Molecular Biology
• Cell Biology

Background:

• Human hematopoietic stem/progenitor cells (HSPCs) are crucial for hematopoiesis and leukemogenesis research.
• The colony forming cell (CFC) assay is a standard method for evaluating hematopoietic progenitor proliferation and differentiation.
• Assessing myeloid differentiation is a key application, though lymphoid differentiation is not directly evaluated.

Purpose of the Study:

• To investigate the impact of oncogenes on the differentiation of primary human CD34+ cells.
• To utilize the CFC assay to analyze oncogene-driven changes in hematopoietic progenitor behavior.
• To establish a method for assessing oncogene effects on myeloid lineage development.

Main Methods:

• Human CD34+ peripheral blood cells were transduced with retroviral vectors encoding either a control or an oncogene (NUP98-HOXA9).
• Pre-activated cells underwent retroviral transduction, followed by isolation of GFP+ cells via fluorescence-activated cell sorting (FACS).
• Cells were cultured in methylcellulose medium for colony formation, followed by analysis of colony number, morphology, flow cytometry, and Giemsa staining.

Main Results:

• The CFC assay allowed for the assessment of colony formation and morphology, providing preliminary differentiation data.
• Flow cytometry and morphologic evaluation of Giemsa-stained cells provided detailed lineage and maturation information.
• Comparison between control and oncogene-transduced cells revealed specific effects of NUP98-HOXA9 on hematopoietic differentiation.

Conclusions:

• The study successfully adapted the CFC assay to evaluate oncogene-induced alterations in human hematopoietic progenitor differentiation.
• The methodology allows for detailed analysis of myeloid lineage commitment and maturation.
• This approach is valuable for understanding the role of oncogenes in hematopoiesis and leukemogenesis.